Skip to main content
. 2020 Dec 24;55:105–111. doi: 10.1016/j.breast.2020.12.009

Table 3.

Health-related quality of life.

Baseline
2–4 weeks after RT
Mean score (SD)
p-valuea Mean score (SD)
p-valuea Clinically important deterioration
5-fraction schedule 15-fraction schedule 5-fraction schedule 15-fraction schedule 5-fraction schedule 15-fraction schedule p-valueb
N 105 94 105 94 105 94
EORT QLQ-C30/BR23
Global health status (QL)c 71.9 (17.2) 72.9 (19.2) p = 0.8 73.9 (14.8) 67.4 (20.5) p = 0.01 16 (15%) 30 (32%) p = 0.005
Functional scalesc
Physical functioning (PF2) 85.1 (16.4) 89.4 (11.6) p = 0.1 87.0 (15.2) 86.8 (13.6) p = 0.6 7 (7%) 23 (24%) p = 0.0005e
Social functioning (SF) 85.1 (21.5) 84.4 (22.5) p = 0.9 87.6 (20.4) 83.0 (21.9) p = 0.03 12 (11%) 29 (31%) p = 0.0007e
Future perspective (BRFU) 60.6 (26.9) 63.1 (26.1) p = 0.5 66.3 (22.9) 59.9 (24.7) p = 0.06 13 (12%) 20 (21%) p = 0.09
Symptom scalesd
Fatigue (FA) 27.5 (19.6) 26.7 (22.6) p = 0.5 28.7 (22.2) 35.2 (23.4) p = 0.07 31 (30%) 47 (50%) p = 0.003e
Pain (PA) 18.7 (21.3) 15.4 (17.7) p = 0.3 16.2 (18.1) 20.2 (21.7) p = 0.2 23 (22%) 35 (37%) p = 0.02
Arm symptoms (BRAS) 10.4 (13.7) 10.4 (15.4) p = 0.7 9.6 (13.2) 9.1 (14.0) p = 0.6 18 (17%) 21 (22%) p = 0.4
Breast symptoms (BRBS) 16.7 (15.6) 15.8 (16.6) p = 0.5 23.7 (17.6) 32.8 (19.9) p = 0.001e 31 (30%) 56 (60%) p = 0.0002e
BREAST-Q
Satisfaction with breast c 74.1 (16.8) 71.6 (17.7) p = 0.5 72.9 (17.5) 67.4 (17.5) p = 0.04 19 (18%) 30 (32%) p = 0.02
Physical well-being d 14.2 (16.5) 12.6 (14.1) p = 0.5 18.4 (18.8) 27.4 (20.3) p = 0.001e 28 (27%) 45 (48%) p = 0.002e
a

Mann Whitney U test.

b

Chi squared test, For botha andb Bonferroni correction is applied (significance level: p < 0,005).

c

Higher score indicates better functioning.

d

Higher score indicates more symptoms.

e

Significance.